UK markets close in 1 hour 6 minutes

Capri Holdings Limited (CPRI)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
35.33+0.08 (+0.23%)
As of 10:22AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 4.11B
Enterprise value 7.57B
Trailing P/E 18.36
Forward P/E 8.19
PEG ratio (5-yr expected) 0.91
Price/sales (ttm)0.80
Price/book (mrq)2.12
Enterprise value/revenue 1.43
Enterprise value/EBITDA 13.08

Trading information

Stock price history

Beta (5Y monthly) 2.05
52-week change 3-5.62%
S&P500 52-week change 323.57%
52-week high 354.52
52-week low 334.17
50-day moving average 343.15
200-day moving average 347.32

Share statistics

Avg vol (3-month) 31.43M
Avg vol (10-day) 32.51M
Shares outstanding 5116.57M
Implied shares outstanding 6116.57M
Float 8113.62M
% held by insiders 12.47%
% held by institutions 187.63%
Shares short (15 Apr 2024) 47.22M
Short ratio (15 Apr 2024) 45.2
Short % of float (15 Apr 2024) 47.20%
Short % of shares outstanding (15 Apr 2024) 46.20%
Shares short (prior month 15 Mar 2024) 46.44M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 01 Apr 2023
Most-recent quarter (mrq)30 Dec 2023

Profitability

Profit margin 3.96%
Operating margin (ttm)9.88%

Management effectiveness

Return on assets (ttm)3.61%
Return on equity (ttm)10.10%

Income statement

Revenue (ttm)5.28B
Revenue per share (ttm)44.55
Quarterly revenue growth (yoy)-5.60%
Gross profit (ttm)N/A
EBITDA 625M
Net income avi to common (ttm)209M
Diluted EPS (ttm)1.92
Quarterly earnings growth (yoy)-53.30%

Balance sheet

Total cash (mrq)249M
Total cash per share (mrq)2.14
Total debt (mrq)3.71B
Total debt/equity (mrq)191.78%
Current ratio (mrq)1.06
Book value per share (mrq)16.64

Cash flow statement

Operating cash flow (ttm)420M
Levered free cash flow (ttm)284.38M